Cargando…

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cancer patients and may be involved in tumor progression. We exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boylan, Kristin L. M., Misemer, Benjamin, DeRycke, Melissa S., Andersen, John D., Harrington, Katherine M., Kalloger, Steve E., Gilks, C. Blake, Pambuccian, Stefan E., Skubitz, Amy P. N.
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083709/ https://www.ncbi.nlm.nih.gov/pubmed/21541062 http://dx.doi.org/10.3390/ijms12021334

Ejemplares similares

Disaggregation and invasion of ovarian carcinoma ascites spheroids
por: Burleson, Kathryn M, et al.
Publicado: (2006)

Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4
por: Boylan, Kristin L.M., et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics
por: Boylan, Kristin LM, et al.
Publicado: (2014)

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
por: Köbel, Martin, et al.
Publicado: (2008)

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
por: Gilks, C. Blake
Publicado: (2010)

Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010)

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
por: Prentice, Leah M, et al.
Publicado: (2007)

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors
por: Skubitz, Keith M, et al.
Publicado: (2008)

A multiplex platform for the identification of ovarian cancer biomarkers
por: Boylan, Kristin L. M., et al.
Publicado: (2017)

Establishment, Characterization and Downstream Application of Primary Ovarian Cancer Cells Derived from Solid Tumors
por: Sueblinvong, Thanasak, et al.
Publicado: (2012)

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
por: Milne, Katy, et al.
Publicado: (2012)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Claudin Proteins in Ovarian Cancer
por: Morin, Patrice J.
Publicado: (2007)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
por: Romani, Chiara, et al.
Publicado: (2021)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics
por: Boylan, Kristin L. M., et al.
Publicado: (2021)

Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
por: Milne, Katy, et al.
Publicado: (2009)

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
por: Milne, Katy, et al.
Publicado: (2013)

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
por: McAlpine, Jessica N, et al.
Publicado: (2009)

Claudins play a role in normal and tumor cell motility
por: Webb, Patricia G, et al.
Publicado: (2013)

Claudin-4 localization in epithelial ovarian cancer
por: Neville, Margaret C., et al.
Publicado: (2022)

The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
por: Boylan, Kristin L.M., et al.
Publicado: (2016)

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
por: Li, Jianghong, et al.
Publicado: (2009)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010)

Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity
por: Misemer, Benjamin S, et al.
Publicado: (2014)

Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma
por: Skubitz, Keith M., et al.
Publicado: (2019)

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration
por: Hicks, Douglas A., et al.
Publicado: (2016)

Model of Ovarian Adenocarcinoma Spheroids for Assessing Photodynamic Cytotoxicity
por: Sokolova, E.A., et al.
Publicado: (2020)

HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
por: Mondal, Susmita, et al.
Publicado: (2015)

Appearance of claudin-5(+) leukocyte subtypes in the blood and CNS during progression of EAE
por: Krajewski, Dylan, et al.
Publicado: (2021)

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
por: Press, Joshua Z, et al.
Publicado: (2008)

Claudin-7 Is Frequently Overexpressed in Ovarian Cancer and Promotes Invasion
por: Dahiya, Neetu, et al.
Publicado: (2011)

Claudin 13, a Member of the Claudin Family Regulated in Mouse Stress Induced Erythropoiesis
por: Thompson, Pamela D., et al.
Publicado: (2010)

Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion
por: Compton, Stephanie L. E., et al.
Publicado: (2022)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

Ovarian carcinoma histotype in Lynch syndrome
por: Gilks, C. Blake, et al.
Publicado: (2017)

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer
por: Boylan, Kristin L. M., et al.
Publicado: (2022)

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
por: Rizzardi, Anthony E, et al.
Publicado: (2012)

Claudin Expression in High Grade Invasive Ductal Carcinoma of the Breast: Correlation with the Molecular Subtype
por: Lu, Shaolei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ahqg0tna07vbcggspqtddq3kc0